Paul Byrne, MD
Obstetrics & Gynecology · Mineola, NYNPI 1801885835
Payments from drug & device makers
Across 201 payments — averaging $45.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$6K
- AbbVie$447
- Astellas Pharma US Inc$424
- Biogen$323
- Exeltis, USA Inc.$223
- Organon$201
- plus $2K from 27 others
What the payments were for
- Consulting fees$170%
- Speaking & faculty fees$5,70062%
- Food & beverage$3,38237%
- Education$1171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 20 | $5,718 |
| AbbVie(2 entities) | 25 | $447 |
| Astellas Pharma US Inc | 17 | $424 |
| Biogen | 15 | $323 |
| Exeltis, USA Inc. | 8 | $223 |
| Organon | 11 | $201 |
| Sumitomo Pharma America, Inc. | 8 | $189 |
| Mayne Pharma Commercial LLC | 12 | $178 |
| Avion Pharmaceuticals | 7 | $126 |
| Coopersurgical, Inc. | 6 | $121 |
| Hologic Sales And Service, LLC | 5 | $113 |
| Applied Medical Resources Corporation | 1 | $109 |
| Therapeuticsmd, Inc. | 6 | $98 |
| Agile Therapeutics, Inc. | 6 | $97 |
| Evofem Biosciences, Inc. | 6 | $93 |
| Pfizer | 5 | $86 |
| Lupin Inc. | 5 | $76 |
| Myovant Sciences Inc. | 4 | $75 |
| Amgen | 3 | $66 |
| Novo Nordisk | 4 | $65 |
| Roche Diagnostics Corporation | 3 | $63 |
| Vertical Pharmaceuticals, LLC | 3 | $46 |
| Merck | 3 | $44 |
| Lilly USA, LLC | 2 | $39 |
| Mission Pharmacal Company | 2 | $32 |
| Scynexis, Inc. | 2 | $32 |
| AMAG Pharmaceuticals, Inc. | 2 | $31 |
| Meditrina | 1 | $28 |
| Bayer | 1 | $28 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Aspira Women's Health Inc | 1 | $17 |
| Channel Medsystems, Inc. | 1 | $8 |
| Unified Women's Healthcare, LP | 5 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$109
How this compares
$9,216 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 14 | $444 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $147 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mineola
- Marina FrimerBronx$8.5M
- Nicole NevadunskyBronx$2.5M
- Jin Hee KimNew York$1M
- Carolyn WesthoffNew York$935K
- Mary PolanNew York$862K
- Jessica AtrioBronx$752K
- Mark MartensAuburn$561K
- Steven GoldsteinNew York$557K
- Sharifa FaziliClarence$430K
- Dhruv AgneshwarJohnson City$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.